Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. - sprookjes - yvandenbroek - TriplyDB

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

http://www.wikidata.org/entity/Q40512049

about

The association between blood glucose and oxidized lipoprotein(a) in healthy young women.The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: a comparison with native lipoprotein(a)Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a)The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis: a comparison with low-density lipoprotein.Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects.Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.

P2860

Q34174653-614191E1-56B8-4809-906A-AFEAB41D64A9 Q35386794-23517F41-9663-4A42-906C-2C87A586DAA0 Q35608863-C7D7F5E0-5B08-468E-A8F0-25B1D53976E6 Q37374146-2661681E-ECD3-4B05-8F82-2A11F293E27A Q42001054-8452D2EC-0772-4120-ADE1-B87017FAB3F5 Q42981013-B2D6C350-E890-4AA2-9894-53F79325F58D Q47606506-68D2405B-751B-40CC-92B1-AFA572AF686B Q51562587-42F837E3-7617-41A4-92A4-05462237408D

P2860

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

http://www.wikidata.org/entity/Q40512049

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

@en

type

label

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

@en

prefLabel

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

@en

P1433

Q40512049-F84164D5-56B8-43DA-B0A7-DB903D1A406E

P1476

Q40512049-B3FEC4D5-426B-4D0F-9087-990A1D66937B

P2093

Q40512049-0DFC566B-057D-4685-809E-46FF787836DF

Q40512049-366E054F-4263-4029-A0AD-9D8D90E22200

Q40512049-694B6122-3CAA-420B-B0EB-7AAA0E72078C

Q40512049-B51ADDCD-99C9-4631-AE5D-FCBA6B72D428

Q40512049-BF5096DD-1192-479C-8C03-2DD954D3AB05

P2860

Q40512049-04257756-7816-4320-B58A-B72522890ED5

Q40512049-053DC861-C69B-4083-9640-F532056401D4

Q40512049-1639FECE-6249-42A1-95D0-80AB845E3638

Q40512049-25C78343-EA18-4129-BD6E-E79B38B3AA00

Q40512049-264625F8-9C5B-4694-8867-A6BAF12F16A4

Q40512049-2CBED9DE-D7B7-4B14-9275-47E35FA08D28

Q40512049-3182A437-F209-45C4-AFFE-9E3035CB932B

Q40512049-3AE925F8-02FA-44B5-B9DE-BE163934DF10

Q40512049-41284E10-6230-420C-9414-575ED616A47F

Q40512049-4996675F-1E2C-4F6B-B3DC-1EE9AC7ADBD1

P304

Q40512049-BE98B248-3354-4BE1-B8D5-0DCB794196C3

P31

Q40512049-358511B3-304D-407C-B1BD-C97E312DC963

P356

Q40512049-C6F42FDA-2651-458E-B248-2BDB538561B2

P407

Q40512049-AF8F9E8B-B888-41D1-B01E-73D9673B6164

P433

Q40512049-FAA9DE7C-8981-43AC-8520-A59E2B8AAE54

P478

Q40512049-0BD67380-C472-41BD-8B9C-301DFD7E6194

P577

Q40512049-BE8880AC-635B-4C47-8A92-441B61EA2689

P5875

Q40512049-8A405936-B571-45A7-BC2F-F066BE668C14

P698

Q40512049-C73165E9-D22E-4888-988D-307E618467A9

P932

Q40512049-90A7C807-43C4-44F1-83C0-587FBA3A5F39

P356

P1433

Journal of Clinical Investigation

P1476

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.

@en

P2093

Eaton DL

http://www.w3.org/2001/XMLSchema#string

Lawn RM

http://www.w3.org/2001/XMLSchema#string

Powell LM

http://www.w3.org/2001/XMLSchema#string

Rice GC

http://www.w3.org/2001/XMLSchema#string

Zioncheck TF

http://www.w3.org/2001/XMLSchema#string

P2860

Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

Macrophage lipoprotein receptors.

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

P304

767-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI115079

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1991-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21329646

http://www.w3.org/2001/XMLSchema#string

P698

1825665

http://www.w3.org/2001/XMLSchema#string

P932

329863

http://www.w3.org/2001/XMLSchema#string